Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T15800 |
LY117018
|
PI3K | PI3K/Akt/mTOR signaling |
LY117018 shows antiproliferative effects on breast cancer cell lines. LY117018 is a Raloxifene analog and is a selective estrogen receptor modulator. | |||
T27884 |
LY 183648
LY-183648,LY183648 |
||
LY 183648 has antiestrogenic activity. LY117018 inhibited PAIII metastasis to the gluteal (97%) and iliac lymph nodes (88%). |